Relates to dispensing certain controlled substances for use by a person with a substance use disorder during certain emergency medical treatment, for use in maintenance or detoxification treatment, or to relieve acute withdrawal symptoms.
Summary
Bill A05432 amends the public health law to allow for the prescription, administration, and dispensing of certain controlled substances specifically for individuals with a substance use disorder. It clarifies that these substances can be provided during emergency medical treatment, for patients suffering from incurable diseases, or for those who are aged or infirm. Additionally, it introduces a new provision that permits practitioners to prescribe specific narcotic drugs for maintenance or detoxification treatment for individuals with substance use disorders.
Impact
The bill modifies existing laws regarding the prescription of controlled substances, particularly focusing on individuals with substance use disorders. By allowing practitioners to prescribe certain narcotics for maintenance and detoxification, it aims to improve access to necessary treatments and support recovery efforts. This change may also influence how healthcare providers approach treatment for substance use disorders, potentially leading to more integrated care for affected individuals.
Sentiment
The sentiment surrounding Bill A05432 appears to be generally supportive, as it addresses a critical public health issue by facilitating better access to treatment for individuals with substance use disorders. However, there may be concerns regarding the potential for misuse of prescribed substances, which could lead to debates in committee discussions and among stakeholders.
Contention
Notable points of contention may arise from concerns about the potential for increased prescription of narcotics and the implications for addiction rates. Some lawmakers and health professionals may advocate for stricter controls or additional safeguards to prevent misuse, while others emphasize the need for more accessible treatment options for those struggling with substance use disorders.
Same As
Relates to dispensing certain controlled substances for use by a person with a substance use disorder during certain emergency medical treatment, or to relieve acute withdrawal symptoms.
Relates to dispensing certain controlled substances for use by a person with a substance use disorder during certain emergency medical treatment, or to relieve acute withdrawal symptoms.
Relates to dispensing certain controlled substances for use by a person with a substance use disorder during certain emergency medical treatment, or to relieve acute withdrawal symptoms.
Increases access to substance use disorder treatment; Requires Medicaid coverage for substance use disorder services provided by community-based organizations.
Increases access to substance use disorder treatment; Requires Medicaid coverage for substance use disorder services provided by community-based organizations.
Modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. (FE)
Modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. (FE)
Allows withdrawals from family tuition accounts to pay for treatment of substance use disorder, including detoxification and rehabilitation for the designated beneficiary.
Allows withdrawals from family tuition accounts to pay for treatment of substance use disorder, including detoxification and rehabilitation for the designated beneficiary.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25